General Information of the Cell Line
Cell Line ID
CL001037
Cell Line Name
CellSensor CRE-bla CHO-K1
Synonyms
CRE-bla CHO-K1
Category
Spontaneously immortalized cell line
Organism
Cricetulus griseus (Chinese hamster)
Tissue Information
Ovary
Disease None
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01688, Sphingosine 1-phosphate receptor 1
Compound ID Compound Name Compound Formula
CP0845571
(S)-5-(3-(1-(2-fluoroethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H23FN4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0845573
(R)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)acetic acid
   Show/Hide
C23H22N4O6S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0845575
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(4-hydroxypiperidin-1-yl)-2-oxoethanesulfonamide
   Show/Hide
C28H31N5O6S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0845577
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)morpholine-4-carboxamide
   Show/Hide
C26H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0845578
(R)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidine-4-carboxylic acid
   Show/Hide
C28H29N5O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0845579
2-isopropoxy-5-(3-(1-(piperazin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C25H27N5O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0845580
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxyethanesulfonamide
   Show/Hide
C23H24N4O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0848222
methyl 1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)azetidine-3-carboxylate
   Show/Hide
C26H26N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0851368
(S)-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypyrrolidine-1-carboxamide
   Show/Hide
C26H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0852162
5-(3-((R)-1-(2-((R)-3-hydroxypyrrolidin-1-yl)-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0861101
(R)-2-(azetidin-1-yl)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)ethanesulfonamide
   Show/Hide
C26H29N5O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0861102
(S)-3-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)propanoic acid
   Show/Hide
C24H24N4O6S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0861105
(S)-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypyrrolidine-1-carboxamide
   Show/Hide
C26H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0861108
5-(3-(1-(4-hydroxypiperidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C26H28N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0861109
(S)-4-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C21H19F3N2O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0861110
(R)-2-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)propanoic acid
   Show/Hide
C24H24N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0861111
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)methanesulfonamide
   Show/Hide
C22H22N4O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0861112
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(dimethylamino)ethanesulfonamide
   Show/Hide
C25H29N5O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864437
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(2-hydroxyethylamino)ethanesulfonamide
   Show/Hide
C25H29N5O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864439
(R)-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypiperidine-1-carboxamide
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864440
(R)-3-amino-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)pyrrolidine-1-carboxamide
   Show/Hide
C26H28N6O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864442
(R)-2-hydroxyethyl 4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate
   Show/Hide
C24H24N4O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864443
(S)-2-(1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidin-4-yl)acetic acid
   Show/Hide
C29H31N5O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864449
5-(3-((R)-1-(((S)-1-hydroxypropan-2-yl)amino)-2,3-dihydro-1H-inden-4-yl)-l,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864457
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N-methylacetamide
   Show/Hide
C24H25N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0864458
5-(3-((R)-1-(((R)-1-hydroxypropan-2-yl)amino)-2,3-dihydro-1H-inden-4-yl)-l,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0867140
(R)-5-(3-(1-hydroxy-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C21H19N3O3
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0869378
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(3-hydroxyazetidin-1-yl)-2-oxoethanesulfonamide
   Show/Hide
C26H27N5O6S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0869391
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)acetamide
   Show/Hide
C23H23N5O3
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0869393
(S)-5-(3-(1-hydroxy-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C21H19N3O3
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0869396
(R)-5-(3-(1-((2-fluoroethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H23FN4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0871093
(S)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylazetidine-3-carboxamide
   Show/Hide
C27H29N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873126
(R)-2-ethoxy-5-(3-(1-hydroxy-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C20H17N3O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873127
5-(3-(1-(4-(2-hydroxyethyl)piperazin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C27H31N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873133
(S)-2-isopropoxy-5-(3-(1-(methylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C22H22N4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873146
5-(3-(1-(2-aminoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H25N5O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873690
3-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)propanoic acid
   Show/Hide
C24H24N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0873691
(S)-4-(5-(4-ethoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C20H17F3N2O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873695
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)acetamide
   Show/Hide
C23H22N4O3
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0873698
(R)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)-N,N-dimethylacetamide
   Show/Hide
C25H27N5O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0873699
(R)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N,N-dimethylazetidine-3-carboxamide
   Show/Hide
C27H29N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0873700
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)morpholine-4-carboxamide
   Show/Hide
C26H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0875568
(R)-2-isopropoxy-5-(3-(1-(2-oxo-2-(pyrrolidin-1-yl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C27H29N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0875571
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypropane-1-sulfonamide
   Show/Hide
C24H26N4O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0875580
(S)-2-((4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)(methyl)amino)acetic acid
   Show/Hide
C24H24N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0875581
(S)-5-(3-(1-((2-hydroxyethyl)(methyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0883362
(R)-5-(3-(1-(bis(2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H28N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0883363
(S)-5-(3-(1-(2,2-difluoroethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H22F2N4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0883364
(R)-2-isopropoxy-5-(3-(1-(methylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C22H22N4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0883365
(S)-2-isopropoxy-5-(3-(1-(propylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0883366
(S)-5-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)pentanoic acid
   Show/Hide
C26H28N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0883369
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-4-(hydroxymethyl)piperidine-1-carboxamide
   Show/Hide
C28H31N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906137
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(3-hydroxyazetidin-1-yl)-2-oxoethanesulfonamide
   Show/Hide
C26H27N5O6S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0906138
(S)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N-methylazetidine-3-carboxamide
   Show/Hide
C26H27N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906139
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)piperazine-1-carboxamide
   Show/Hide
C26H28N6O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906142
(S)-methyl 2-(1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidin-4-yl)acetate
   Show/Hide
C30H33N5O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906143
(R)-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypyrrolidine-1-carboxamide
   Show/Hide
C26H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906144
(R)-methyl 1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidine-4-carboxylate
   Show/Hide
C29H31N5O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906146
(S)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)guanidine
   Show/Hide
C22H22N6O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906173
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)cyclopropanesulfonamide
   Show/Hide
C24H24N4O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906174
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)cyclopropanesulfonamide
   Show/Hide
C24H24N4O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906179
(S)-methyl 3-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)propanoate
   Show/Hide
C25H26N4O6S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906183
5-(3-(1-((R)-2,3-dihydroxypropylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906185
(R)-4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C21H22N2O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906186
(R)-2-amino-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)acetamide
   Show/Hide
C23H23N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906188
(R)-5-(3-(1-(3-hydroxyazetidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H24N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906196
5-(3-((R)-1-(2-((S)-3-hydroxypyrrolidin-1-yl)-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906198
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(dimethylamino)acetamide
   Show/Hide
C25H27N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0919536
(R)-3-((4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-yl)amino)propanoic acid
   Show/Hide
C24H24N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0919537
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(methylamino)ethanesulfonamide
   Show/Hide
C24H27N5O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0919540
(S)-2-(azetidin-1-yl)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-oxoethanesulfonamide
   Show/Hide
C26H27N5O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0919542
(R)-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypyrrolidine-1-carboxamide
   Show/Hide
C26H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0919543
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-4-hydroxypiperidine-1-carboxamide
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0933050
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-ethoxyethanesulfonamide
   Show/Hide
C25H28N4O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0933052
(S)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)-N-methylacetamide
   Show/Hide
C24H25N5O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0933055
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamide
   Show/Hide
C21H21N5O4S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0933078
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxy-N-methylacetamide
   Show/Hide
C24H24N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946700
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxyacetamide
   Show/Hide
C23H22N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0946701
(S)-methyl 4-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)butanoate
   Show/Hide
C26H28N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0946703
(S)-2-hydroxyethyl 4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate
   Show/Hide
C24H24N4O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946716
rac-methyl 3-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)propanoate
   Show/Hide
C25H26N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946717
N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methoxyacetamide
   Show/Hide
C24H24N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946719
5-(3-(1-((1,3-dihydroxypropan-2-yl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-iso-propoxybenzonitrile
   Show/Hide
C23H24N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946723
(S)-5-(3-(1-(ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H24N4O2
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946725
(R)-5-(3-(1-(ethyl(2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H28N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946727
(S)-3-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-1,1-dimethylurea
   Show/Hide
C24H25N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946728
(R)-2-isopropoxy-5-(3-(1-((2-(methylsulfonyl)ethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946730
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N-(2-hydroxyethyl)acetamide
   Show/Hide
C25H27N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946731
(S)-2-isopropoxy-5-(3-(1-(thiazol-5-ylmethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C25H23N5O2S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0946732
(S)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)acetamide
   Show/Hide
C23H23N5O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0947296
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)acetamide
   Show/Hide
C23H22N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0947297
(R)-methyl(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-y1)-2,3-dihydro-1H-inden-1-yl)carbamate
   Show/Hide
C23H22N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0947298
(S)-methyl 4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate
   Show/Hide
C23H22N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0947299
(R)-2-isopropoxy-5-(3-(1-(2-oxooxazolidin-3-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H22N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0947300
(S)-2-isopropoxy-5-(3-(1-(2-oxooxazolidin-3-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H22N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0947301
(R)-2-(azetidin-1-yl)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-oxoethanesulfonamide
   Show/Hide
C26H27N5O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0947302
(S)-methyl 1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidine-4-carboxylate
   Show/Hide
C29H31N5O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0947303
(S)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidine-4-carboxylic acid
   Show/Hide
C28H29N5O5
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0949438
2-isopropoxy-5-(3-(1-(2-(methylsulfonyl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0949439
2-((4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)amino)-N-methylethanesulfonamide
   Show/Hide
C24H27N5O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0949440
5-(3-((S)-1-(((R)-1-hydroxypropan-2-yl)amino)-2,3-dihydro-1H-inden-4-yl)-l,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0949762
(S)-4-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)butanoic acid
   Show/Hide
C25H26N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0949766
5-(3-(1-((S)-2,3-dihydroxypropylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0949767
5-(3-(1-((S)-2-hydroxypropylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0949776
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-morpholino-2-oxoethanesulfonamide
   Show/Hide
C27H29N5O6S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0949777
(R)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)-N-methylacetamide
   Show/Hide
C24H25N5O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0950215
(S)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)-N,N-dimethylacetamide
   Show/Hide
C25H27N5O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0950217
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(dimethylamino)acetamide
   Show/Hide
C25H27N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0955060
2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethyl acetate
   Show/Hide
C25H26N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0955065
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxyacetamide
   Show/Hide
C23H22N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0955067
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-yl)methanesulfonamide
   Show/Hide
C22H22N4O4S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0958194
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)acetic acid
   Show/Hide
C23H22N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0958195
(S)-5-(3-(1-(3-hydroxyazetidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H24N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0958197
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-morpholino-2-oxoethanesulfonamide
   Show/Hide
C27H29N5O6S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0958198
(S)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)azetidine-3-carboxylic acid
   Show/Hide
C25H24N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0961368
(S)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)acetic acid
   Show/Hide
C23H22N4O6S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0963597
(R)-2-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)acetamide
   Show/Hide
C23H23N5O5S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0963598
(R)-1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)azetidine-3-carboxylic acid
   Show/Hide
C25H24N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0964204
methyl 5-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)pentanoate
   Show/Hide
C27H30N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0964206
N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-((R)-3-hydroxypyrrolidin-1-yl)ethanesulfonamide
   Show/Hide
C27H31N5O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0964207
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(3-hydroxyazetidin-1-yl)ethanesulfonamide
   Show/Hide
C26H29N5O5S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0966078
(S)-4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C21H22N2O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0966079
(S)-2-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)propanoic acid
   Show/Hide
C24H24N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0966080
(S)-2-isopropoxy-5-(3-(1-(2-methoxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0966082
(S)-2-isopropoxy-5-(3-(1-(2-(methylsulfonyl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O4S
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0966787
N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-ethoxyacetamide
   Show/Hide
C25H26N4O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0966789
(R)-2-isopropoxy-5-(3-(1-(2-morpholino-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0966790
(S)-2-ethoxy-5-(3-(1-hydroxy-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C20H17N3O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0967385
1-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)azetidine-3-carboxylic acid
   Show/Hide
C25H24N4O4
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0967388
(R)-5-(3-(1-(2-(azetidin-1-yl)-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C26H27N5O3
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0967392
5-(3-cyano-4-isopropoxy-phenyl)-3-[(1S)-1-(sulfamoylamino)indan-4-yl]-1,2,4-oxadiazole
   Show/Hide
C21H21N5O4S
 1
1
EC50 < 0.05 nM
   TI
   LI
   LO
   TS
CP0967394
(S)-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypiperidine-1-carboxamide
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.05 nM
   TI
   LI
   LO
   TS
CP0906147
(S)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N,N-dimethylacetamide
   Show/Hide
C25H27N5O3
 1
1
EC50 = 0.09 nM
   TI
   LI
   LO
   TS
CP0906148
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-meth-oxyethanesulfonamide
   Show/Hide
C24H26N4O5S
 1
1
EC50 = 0.09 nM
   TI
   LI
   LO
   TS
CP0848223
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxyazetidine-1-carboxamide
   Show/Hide
C25H25N5O4
 1
1
EC50 = 0.1 nM
   TI
   LI
   LO
   TS
CP0861106
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-hydroxyethanesulfonamide
   Show/Hide
C23H24N4O5S
 1
1
EC50 = 0.1 nM
   TI
   LI
   LO
   TS
CP0873702
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-l,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxyazetidine-1-carboxamide
   Show/Hide
C25H25N5O4
 1
1
EC50 = 0.1 nM
   TI
   LI
   LO
   TS
CP0848219
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N,N-dimethylacetamide hydrochloride
   Show/Hide
C25H28ClN5O3
 1
1
EC50 = 0.13 nM
   TI
   LI
   LO
   TS
CP0248629
Ozanimod
   Show/Hide
C23H24N4O3
 1
1
EC50 = 0.16 nM
   TI
   LI
   LO
   TS
CP0861107
(+/-)-4-(5-(3,4,diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C21H22N2O4
 1
1
EC50 = 0.16 nM
   TI
   LI
   LO
   TS
CP0883372
(R)-5-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H24N4O3
 1
1
EC50 = 0.16 nM
   TI
   LI
   LO
   TS
CP0883375
(R)-5-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxy-benzonitrile hydrochloride
   Show/Hide
C21H21ClN4O2
 1
1
EC50 = 0.17 nM
   TI
   LI
   LO
   TS
CP0871098
(S)-5-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C21H20N4O2
 1
1
EC50 = 0.19 nM
   TI
   LI
   LO
   TS
CP0845581
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methoxyethanesulfonamide
   Show/Hide
C24H26N4O5S
 1
1
EC50 = 0.36 nM
   TI
   LI
   LO
   TS
CP0845572
N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-((S)-3-hydroxypyrrolidin-1-yl)ethanesulfonamide
   Show/Hide
C27H31N5O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0845576
(S)-5-(3-(1-(dimethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H24N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0848218
(R)-2-isopropoxy-5-(3-(1-(2-methoxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0848221
(S)-5-(3-(1-(benzylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C28H26N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0848224
(R)-2-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N,N-diethylacetamide
   Show/Hide
C27H31N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0852163
(S)-5-(3-(1-(((1H-imidazol-2-yl)methyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isobutoxybenzonitrile
   Show/Hide
C25H24N6O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0852164
N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-((S)-3-hydroxypyrrolidin-1-yl)ethanesulfonamide
   Show/Hide
C27H31N5O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0861103
(S)-3-amino-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)pyrrolidine-1-carboxamide
   Show/Hide
C26H28N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0861104
(R)-methyl 2-(1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidin-4-yl)acetate
   Show/Hide
C30H33N5O5
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0864434
2-isopropoxy-5-(3-((S)-1-(((2R,3S,4R)-2,3,4,5-tetrahydroxypentyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C26H30N4O6
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0864435
(R)-2-isopropoxy-5-(3-(1-(2-oxo-2-(piperidin-1-yl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C28H31N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0864436
(S)-2-isopropoxy-5-(3-(1-((4-methyl-1H-imidazol-2-yl)methylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C26H26N6O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0864438
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)methane sulfonamide
   Show/Hide
C28H29N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0864441
(S)-3-amino-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)pyrrolidine-1-carboxamide
   Show/Hide
C26H28N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0869392
(R)-4-(5-(4-ethoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C20H17F3N2O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873077
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N-(2-hydroxyethyl)acetamide
   Show/Hide
C25H26N4O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873078
(R)-2-((4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)(methyl)amino)-N,N-dimethylacetamide
   Show/Hide
C26H29N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873082
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-morpholinoethanesulfonamide
   Show/Hide
C27H31N5O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873119
5-(3-(1-((1-hydroxy-2-methylpropan-2-yl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H28N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873128
2-isopropoxy-5-(3-(1-(2-morpholinoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C27H31N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873130
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(methylamino)ethanesulfonamide
   Show/Hide
C24H27N5O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873132
5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isobutoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873147
(R)-5-(3-(1-(2-hydroxy-2-methylpropylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H28N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873688
2-isopropoxy-5-(3-(1-(2-(pyrrolidin-1-yl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C27H31N5O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873689
5-(3-(1-((R)-3-hydroxypyrrolidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873692
(R)-4-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C21H19F3N2O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873696
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(pyrrolidin-1-yl)ethanesulfonamide
   Show/Hide
C27H31N5O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0873697
N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-((R)-3-hydroxypyrrolidin-1-yl)ethanesulfonamide
   Show/Hide
C27H31N5O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0875570
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(piperidin-1-yl)ethanesulfonamide
   Show/Hide
C28H33N5O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0883356
5-(3-(1-(2-(diethylamino)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C27H33N5O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0883361
(R)-5-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-y1)-2-(cyclopropylmethoxy)benzonitrile
   Show/Hide
C22H20N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0883367
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)piperazine-1-carboxamide
   Show/Hide
C26H28N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0906140
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-4-(hydroxymethyl)piperidine-1-carboxamide
   Show/Hide
C28H31N5O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0906141
(R)-3-amino-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)pyrrolidine-1-carboxamide
   Show/Hide
C26H28N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0906145
(R)-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-(dimethylamino)pyrrolidine-1-carboxamide
   Show/Hide
C28H32N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0906176
(S)-2-(azetidin-1-yl)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)ethanesulfonamide
   Show/Hide
C26H29N5O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0906177
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(4-hydroxypiperidin-1-yl)ethanesulfonamide
   Show/Hide
C28H33N5O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0906178
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(piperazin-1-yl)ethanesulfonamide
   Show/Hide
C27H32N6O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0919539
(S)-2-isopropoxy-5-(3-(1-((3-methyl-1H-pyrazol-5-yl)methylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C26H26N6O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0919541
(R)-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypiperidine-1-carboxamide
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0930893
2-isopropoxy-5-(3-(1-morpholino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C25H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933051
(S)-methyl 3-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)-2,2-dimethylpropanoate
   Show/Hide
C27H30N4O6S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933053
(S)-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-(dimethylamino)pyrrolidine-1-carboxamide
   Show/Hide
C28H32N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933061
2-isopropoxy-5-(3-(1-(2-(methylamino)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H27N5O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933071
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(dimethylamino)ethanesulfonamide
   Show/Hide
C25H29N5O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933072
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)benzenesulfonamide
   Show/Hide
C27H24N4O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933073
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-1-phenylmethanesulfonamide
   Show/Hide
C28H26N4O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0933079
(R)-5-(3-(1-((2-hydroxyethyl)(methyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946702
(R)-ethyl 4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate
   Show/Hide
C24H24N4O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946704
(S)-5-(3-(1-((1H-benzo[d]imidazol-2-yl)methylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C29H26N6O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946715
5-(3-(1-((S)-3-hydroxypyrrolidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946718
(R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl acetate
   Show/Hide
C23H21N3O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946720
(S)-2-isopropoxy-5-(3-(1-(isopropylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C24H26N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946722
(R)-2-(4-(5-(3-bromo-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanol
   Show/Hide
C22H24BrN3O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946724
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N-(2-hydroxyethyl)methanesulfonamide
   Show/Hide
C24H26N4O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0946729
(R)-5-(3-(1-(2-(aziridin-1-yl)-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H25N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0949768
(S)-4-(5-(4-ethoxy-3-nitrophenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C19H17N3O5
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0949769
2-isopropoxy-5-(3-(1-(tetrahydro-2H-pyran-4-ylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C26H28N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0949778
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-4-hydroxypiperidine-1-carboxamide
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0949779
(S)-N-((S)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-(dimethylamino)pyrrolidine-1-carboxamide
   Show/Hide
C28H32N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0949780
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-4-(dimethylamino)piperidine-1-carboxamide
   Show/Hide
C29H34N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0949830
(R)-4-(5-(4-isopropoxy-3-(methylsulfonyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-amine
   Show/Hide
C21H23N3O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955061
5-(3-((S)-1-(((S)-1-hydroxypropan-2-yl)amino)-2,3-dihydro-1H-inden-4-yl)-l,2,4-oxadiazo1-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955063
(R)-4-(5-(4-ethoxy-3-nitrophenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol
   Show/Hide
C19H17N3O5
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955066
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-(pyrrolidin-1-yl)acetamide
   Show/Hide
C27H29N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955068
(S)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)ethanesulfonamide
   Show/Hide
C23H24N4O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955069
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-methylpropane-1-sulfonamide
   Show/Hide
C25H28N4O4S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955070
(R)-5-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-ethoxybenzonitrile
   Show/Hide
C20H18N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955071
(R)-2-((4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)(ethyl)amino)-N,N-dimethylacetamide
   Show/Hide
C27H31N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955072
(R)-2-isopropoxy-5-(3-(1-(2-(4-methylpiperazin-1-yl)-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C28H32N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0955074
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-2-morpholinoethanesulfonamide
   Show/Hide
C27H31N5O5S
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0958205
(R)-5-(3-(1-(2,2-difluoroethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C23H22F2N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0962595
(S)-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-hydroxypiperidine-1-carboxamide
   Show/Hide
C27H29N5O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0964205
(R)-5-(3-(1-(benzylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C28H26N4O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0964210
5-(3-(1-((R)-2-hydroxypropylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C24H26N4O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0966786
5-(3-(1-((S)-3-aminopyrrolidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H27N5O2
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0966788
2-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)-N,N-dimethylpropanamide
   Show/Hide
C26H29N5O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0967389
(S)-ethyl 4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamate
   Show/Hide
C24H24N4O4
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0967390
(R)-2-(1-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylcarbamoyl)piperidin-4-yl)acetic acid
   Show/Hide
C29H31N5O5
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0967391
(R)-N-((R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-3-(dimethylamino)pyrrolidine-1-carboxamide
   Show/Hide
C28H32N6O3
 1
1
EC50 = 0.5 nM
   TI
   LI
   LO
   TS
CP0871095
(+/-)-2-((4-(5-(3,4,diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)amino)ethanol
   Show/Hide
C23H27N3O4
 1
1
EC50 = 2.88 nM
   TI
   LI
   LO
   TS
CP0848220
2-hydroxy-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C20H18N4O3
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0861113
(R)-4-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)benzoic acid
   Show/Hide
C28H24N4O6S
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0864456
2-isopropoxy-5-(3-(1-(piperidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C26H28N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0869394
(R)-4-(5-(3-chloro-4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-amine
   Show/Hide
C20H20ClN3O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0869395
2-isopropoxy-5-(3-((S)-1-((S)-1-phenylethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C29H28N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0873129
2-isopropoxy-5-(3-(1-(2-(piperidin-1-yl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C28H33N5O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0873131
(R)-3-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)-5-(trifluoromethoxy)benzonitrile
   Show/Hide
C19H13F3N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0873693
rac-5-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-(2-methoxyethoxy)benzonitrile
   Show/Hide
C23H24N4O4
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0873694
2-(2-cyano-4-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)phenoxy)acetic acid
   Show/Hide
C22H20N4O5
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0875569
(R)-2-isopropoxy-5-(3-(1-(2-oxo-2-(piperazin-1-yl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C27H30N6O3
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0883357
2-isopropoxy-5-(3-(1-(piperidin-4-ylamino)-2,3-dihydro-4H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C26H29N5O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0906184
(R)-4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl pivalate
   Show/Hide
C26H27N3O4
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0906190
(R)-4-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitri1e
   Show/Hide
C21H20N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0906191
2-cyano-4-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)phenyl isobutyrate
   Show/Hide
C24H24N4O4
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0906192
(S)-5-(3-(1-(2-(dimethylamino)-2-oxoethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzamide
   Show/Hide
C25H29N5O4
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0906194
(R)-4-bromo-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)benzamide
   Show/Hide
C28H23BrN4O3
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0919538
(R)-4-(5-(4-isopropoxyphenyl)-1,2,4-oxadiazo1-3-yl)-2,3-dihydro-1H-inden-1-amine
   Show/Hide
C20H21N3O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0919544
2-isopropoxy-5-(3-((R)-1-((R)-1-phenylethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C29H28N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0933054
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-4-(dimethylamino)piperidine-1-carboxamide
   Show/Hide
C29H34N6O3
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0933074
(R)-3-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)benzonitrie
   Show/Hide
C18H14N4O
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0946721
(R)-3-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazo1-5-yl)-5-isopropoxybenzonitrile
   Show/Hide
C21H20N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0946726
(R)-N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N-(2-hydroxyethyl)benzenesulfonamide
   Show/Hide
C29H28N4O5S
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0947294
(R)-N-(4-(N-(4-(5-(3-cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)sulfamoyl)phenyl)acetamide
   Show/Hide
C29H27N5O5S
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0955059
2-isopropoxy-5-(3-(1-(2-(piperazin-1-yl)ethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C27H32N6O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0955064
5-(3-(1-(cyclohexylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C27H30N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0958196
2-((S)-2,3-dihydroxypropoxy)-5-(3-(1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
   Show/Hide
C23H24N4O5
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0964209
5-(3-(1-((R)-3-aminopyrrolidin-1-yl)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
   Show/Hide
C25H27N5O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
CP0967387
(R)-3-(3-(1-amino-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-4-isopropoxybenzonitrile
   Show/Hide
C21H20N4O2
 1
1
EC50 > 5 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Ovary)
Cell Line Name Organism Disease
SW626 Homo sapiens (Human) Colon adenocarcinoma
FU-OV-1 Homo sapiens (Human) High grade ovarian serous adenocarcinoma
TOV-21G Homo sapiens (Human) Ovarian clear cell adenocarcinoma
ES-2 Homo sapiens (Human) Ovarian clear cell adenocarcinoma
A2780 Homo sapiens (Human) Ovarian endometrioid adenocarcinoma
A2780ADR Homo sapiens (Human) Ovarian endometrioid adenocarcinoma
IGROV-1 Homo sapiens (Human) Ovarian endometrioid adenocarcinoma
CHO Cricetulus griseus (Chinese hamster) -
CHO-K1 Cricetulus griseus (Chinese hamster) -
CHO/Galpha16 Cricetulus griseus (Chinese hamster) -
CHOP Cricetulus griseus (Chinese hamster) -
T-REx-CHO Cricetulus griseus (Chinese hamster) -
CHO Pro-4 MtxRII OuaR-2-4 Cricetulus griseus (Chinese hamster) -
Flp-In-CHO Cricetulus griseus (Chinese hamster) -
CHO-DXB11 Cricetulus griseus (Chinese hamster) -
CHO-CPR C10 Cricetulus griseus (Chinese hamster) -
PathHunter CHO-K1 EDG1 beta-arrestin Cricetulus griseus (Chinese hamster) -
CHO-S Cricetulus griseus (Chinese hamster) -
CHO-7 Cricetulus griseus (Chinese hamster) -
CHO-T Cricetulus griseus (Chinese hamster) -
ValiScreen human CRTH2 Cricetulus griseus (Chinese hamster) -
PathHunter CHO-K1 GLP1R beta-arrestin-1 Cricetulus griseus (Chinese hamster) -
CHO-K1/CRE-Luc Cricetulus griseus (Chinese hamster) -
CHO-hTRPV1 Cricetulus griseus (Chinese hamster) -
Lec1 Cricetulus griseus (Chinese hamster) -
CHO-N9 Cricetulus griseus (Chinese hamster) -
CHO/IR Cricetulus griseus (Chinese hamster) -
CHO-K1/Gqi5 Cricetulus griseus (Chinese hamster) -
CHO-K9 Cricetulus griseus (Chinese hamster) -
CHO-A12 Cricetulus griseus (Chinese hamster) -
CHO E1a Cricetulus griseus (Chinese hamster) -
PathHunter CHO-K1 CXCR7 beta-arrestin Cricetulus griseus (Chinese hamster) -
R2/PCFT4 Cricetulus griseus (Chinese hamster) -
Chinese hamster RT16 Cricetulus griseus (Chinese hamster) -
CHO-A1 Cricetulus griseus (Chinese hamster) -
CHO-D-/aequorin Cricetulus griseus (Chinese hamster) -
CHO-DUKX-A2 Cricetulus griseus (Chinese hamster) -
Lec3.2.8.1 Cricetulus griseus (Chinese hamster) -
CellSensor NFAT-bla CHO-K1 Cricetulus griseus (Chinese hamster) -
Chinese hamster PC43-10 Cricetulus griseus (Chinese hamster) -
CHO-A3 Cricetulus griseus (Chinese hamster) -
CHO/VR1 Cricetulus griseus (Chinese hamster) -
CHO-hgamma Cricetulus griseus (Chinese hamster) -
CHO-1 Cricetulus griseus (Chinese hamster) -
CHO-03 Cricetulus griseus (Chinese hamster) -
CHO CGE Cricetulus griseus (Chinese hamster) -
CHO-CHRM2 Cricetulus griseus (Chinese hamster) -
CHO CRE-SPAP Cricetulus griseus (Chinese hamster) -
CHO 2B7 Cricetulus griseus (Chinese hamster) -
hMORCHO Cricetulus griseus (Chinese hamster) -
CHO Pro-5 Cricetulus griseus (Chinese hamster) -
CHO CCR3/2 Cricetulus griseus (Chinese hamster) -
PPLS-HA-GPR88 CHO Cricetulus griseus (Chinese hamster) -
hTRPV4/CHO Cricetulus griseus (Chinese hamster) -
CHO 1827 Cricetulus griseus (Chinese hamster) -
CHO ducX#98 Cricetulus griseus (Chinese hamster) -
CHO 1829 Cricetulus griseus (Chinese hamster) -
CHO-mtAEQ Cricetulus griseus (Chinese hamster) -
DHB-11 CHO Cricetulus griseus (Chinese hamster) -
PathHunter CHO-K1 GLP1R beta-arrestin-2 Cricetulus griseus (Chinese hamster) -
Sf21 Spodoptera frugiperda (Fall armyworm) -
Sf9 Spodoptera frugiperda (Fall armyworm) -
SF-12 Spodoptera frugiperda (Fall armyworm) -
Tni PRO Trichoplusia ni (Cabbage looper) -